Leadership

Oxana Polyakova, Ph.D

Oxana Polyakova, Ph.D., is the chief scientific officer of LAVA Therapeutics. Most recently, Oxana served as chief scientific officer at LIfT BioSciences. She was founding scientist and served as Head of Discovery at Adaptate Biotherapeutics, spin-out of GammaDelta Therapeutics. Over her 20-year career to date, Oxana has worked across multiple therapeutic modalities in both pharma and biotech settings, with significant experience discovering biologics and developing cell therapies for Oncology indications. Oxana holds a Ph.D. from Moscow State University.